Chemical structures have been identified which allosterically modify pyrvate kinase and inhibit enzymatic activity. These compounds can be used as pharmaceuticals in the treatment of a wide variety of diseases and disorders where influencing metabolic processes is beneficial, such as the glycolytic pathway, all pathways which use ATP as an energy source, and all pathways which involve 2,3-diphosphoglycerate related to the delivery of oxygen by modifying hemoglobin's oxygen affinity, treatments of tumor and cancer and Alzheimer's disease (AD).
已经鉴定出一些
化学结构,可以使变构酶发生变异并抑制其酶活性。这些化合物可用作药物,用于治疗各种疾病和障碍,其中影响代谢过程有益的疾病,例如糖酵解途径,所有使用
ATP作为能源的途径,以及所有涉及
2,3-二磷酸甘油酸与通过修改血红蛋白的氧亲和力来传递氧的途径,肿瘤和癌症以及阿尔茨海默病(AD)的治疗。